22312100Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MRJournal of clinical oncology : official journal of the American Society of Clinical OncologyAntineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Lymphoma; Salvage TherapyAdult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Interleukin-15; Interleukin-7; Lymphocyte Depletion; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vidarabine; VincristineDose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol. 2012 Mar 10; 30(8):830-6.J Clin Oncol2012-02-06T00:00:002012Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD000970Chemicals & Drugs40723510.435494Antineoplastic AgentsD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD003520Chemicals & Drugs1242990.920632CyclophosphamideD005047Chemicals & Drugs621960.939627EtoposideD005434Procedures2836790.849135Flow CytometryD008212Procedures50970.965017Lymphocyte DepletionD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD005260Physiology1992444050.191184FemaleD011241Chemicals & Drugs1132550.929584PrednisoneD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD018380Procedures1408780.592702Hematopoietic Stem Cell TransplantationD014740Chemicals & Drugs191410.950588VidarabineMedicine-Hematology and OncologyD016879Procedures972320.889684Salvage TherapyD008223Disorders1142620.859127LymphomaD015851Chemicals & Drugs19410.976732Interleukin-7D016896Concepts & Ideas101179490.402421Treatment OutcomeD019409Chemicals & Drugs24720.937526Interleukin-15D014750Chemicals & Drugs501110.971572VincristineD058846Chemicals & Drugs53780.969624Antibodies, Monoclonal, Murine-DerivedD000069283671160.945262RituximabD004317Chemicals & Drugs1302890.919426DoxorubicinUniversity of Chicagotrue1ProfessorProfessor1010Michael R.BishopMichael R. Bishop0.000000000000000.000000000000002689Bishop, Michael R.ProfessorAuthorship 59730140.4310010.4310011authors10.2524has subject area